Century Therapeutics Inc

NASDAQ:IPSC   4:00:00 PM EDT
10.35
-0.18 (-1.71%)
4:02:16 PM EDT: $10.35 0.00 (0.00%)
Products

Century Therapeutics Provides Pipeline Updates

Published: 11/11/2022 12:26 GMT
Century Therapeutics Inc (IPSC) - Century Therapeutics Announces Presentation of Preclinical Data at the Sitc 37th Annual Meeting and Provides Pipeline Updates.
Century Therapeutics Inc - Company Announces Nomination of Next Pipeline Program, Cnty-107 a Nectin-4 Car Gamma Delta It Product Candidate.
Century Therapeutics Inc - Expects to File an Investigational New Drug (ind) Application in 2025 for Nectin-4+ Cancers.